# A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke

Study · id `cardio:ct-nct04126486` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04126486](<https://clinicaltrials.gov/study/NCT04126486>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04126486

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 11931 participants.

## Technical summary

Registry record NCT04126486. Randomized; no masking; primary purpose prevention. Start 2019-12-17 (actual); primary completion 2023-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 11931 participants (enrolled count; ClinicalTrials.gov record NCT04126486, source copy `cardio:ctgov-nct04126486-2023-07-12`, retrieved 2026-10-26)
- Started: 2019-12-17 (actual) (ClinicalTrials.gov record NCT04126486, source copy `cardio:ctgov-nct04126486-2023-07-12`, retrieved 2026-10-26)
- Primary completion: 2023-06-30 (actual) (ClinicalTrials.gov record NCT04126486, source copy `cardio:ctgov-nct04126486-2023-07-12`, retrieved 2026-10-26)
- Completion: 2023-06-30 (actual) (ClinicalTrials.gov record NCT04126486, source copy `cardio:ctgov-nct04126486-2023-07-12`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04126486, source copy `cardio:ctgov-nct04126486-2023-07-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04126486-2023-07-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
- Acronym: GUARD-AF
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Intervention (Other): Zio®XT Monitor
- Lead sponsor: Bristol-Myers Squibb
- Lead sponsor class: INDUSTRY
- Collaborator: Pfizer
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry lists this organization as the lead sponsor: Bristol-Myers Squibb (`cardio:org-bristol-myers-squibb`)
- Registry lists this organization as a collaborator: Pfizer (`cardio:org-pfizer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention (`cardio:pubmed-39230544`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening Arm (`cardio:pubmed-39297839`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: bb00ff29010da4c9f40e66cc35de0cad4743b5a832907fb17d3c1c5e0763cc9e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
